Biomaterials, Biodegradables and Biomimetics Research Group

Papers in Scientific Journals

Natural based eumelanin nanoparticles functionalization and preliminary evaluation as carrier for gentamicin

Abstract

Purpose of the work was to modified natural based eumelanin nanoparticles surface by dopamine self-polymerization (FEUNp), facilitating conjugation through polydopamine bioactive functional groups and improving nanoparticle surface hydrophilicity. SEM, TEM, and AFM characterization confirmed FEUNp spherical shape (230.04 ± 8.25 nm) and their polydopamine coating. Individual indole or indoline structure spectrum at 1600 cm− 1 and C:N mass 9.08 was highlighted by FTIR and XPS analysis respectively. Quartz-crystal microbalance with dissipation monitoring (QCM-D) and thermal gravimetric analysis (TGA) showed successful polydopamine adsorption to eumelanin nanoparticles surface, a weight ratio of eumelanin nanoparticles/dopamine of 1/2.46 in the wet state and 1/0.20 in the dry state; the − 36.60 ± 0.45 mV negatively surface charges confirms the presence of PD covering. FEUNp were loaded with gentamicin sulfate, for application in infectious diseases therapies, such as osteomyelitis. Nanoparticles drug entrapment efficiency was 32.42 ± 3.21%, and ζ-potential close to neutrality (− 1.84 ± 0.58 mV). FEUNp-GS antimicrobial effect was tested on Staphylococcusaureus and Escherichiacoli showing gentamicin 24 h sustained release from FEUNp-GS. IC50 and IC90 were 110.60 μg/mL and 216.39 μg/mL against Saureus, and 54.13 μg/mL and 101.25 μg/mL against Ecoli. The results are promising for FEUNp-GS as delivery system potentially useful diverse administration routes.

Journal
Reactive & Functional Polymers
Volume
114
Pagination
38-48
Publisher
Elsevier
ISSN
1381-5148
URL
www.sciencedirect.com/science/article/pii/S1381514817300391
Keywords
Drug delivery systems, Eumelanin nanoparticles, gentamicin, Polydopamine, Surface modification
Rights
Restricted Access
Peer Reviewed
Yes
Status
published
This website uses cookies. By using this website you consent to our use of these cookies. For more information visit our Policy Page.